Note also that the compounding market tightened in 2025 to 2026 after the FDA removed semaglutide and tirzepatide from shortage, so pharmacy access to compounded products now generally requires a documented clinical rationale
Some people feel a slight reduction in appetite
Clinical trials, including a randomized clinical trial, proved it helps lower blood sugar levels and improve glycemic control for those with this condition
Therefore, in the clinical treatment of type 2 diabetes, the GLP-1 receptor agonist Semaglutide is a scientific therapeutic agent
The honest answer is this: weight loss injection side effects are real, but most are mild, short-lived, and well-managed under a doctors guidance
However, as we have written extensively about over the course of the past two years, we are deeply concerned about healthcare affordability